SOPHiA Genetics Analysts Set Average Hold Rating, Target at $10
SOPHiA GENETICS SA received an average Hold recommendation from five covering brokerages, with a $10.00 average 12‑month price target. BTIG Research raised its target from $8.00 to $9.00 and assigned a buy rating. The stock fell 0.9% amid disclosed insider selling, including CEO sales totaling $290,400.20 and another insider sale of $123,930.